| Ronak Journal

Moving forward together with science that treats, inspired by the people we serve.

Ronak’s portfolio includes high-quality, innovative pharmaceuticals developed to meet essential patient needs and elevate the standards of treatment across the country.

Cardiovascular Diseases
Neurological Diseases
Psychiatric Disorders
Autoimmune and Inflammatory Diseases
Oncology & Hematology Diseases
Endocrine and Metabolic Diseases
Gastrointestinal Diseases
Rheumatology and Orthopedic Diseases
Radiology / Diagnostic
Protamine Sulfate
Muscle Relaxant
Depressive Disorder
Anxiety Disorders
Non-opioid analgesics
Antibiotics
Antiviral Drugs
Antifungal Drugs
Diabetes
Acid Reflux
Chronic Kidney Disease
Neurogenic Bladder
Benign Prostatic Hyperplasia
Antibiotic
Coronary Artery Disease
Heart Failure
High Blood Pressure
Seizure Disorders
Epilepsy/Seizures
Reproductive Health & Fertility

Ronacare Healthcare Journal News & Events Contact us

Back to Journal

Anesthesia

April 19, 2026

This content is approved by Ronak's medical team

Submit Feedback

test222

Published by Ronak Pharmaceutical Co.

Submit Feedback

Related Articles

test222